YH-53

N/A

Report date: 2023/05/22 10:19:17
NME

Base Information

Drug NameYH-53
Drug Alias NameYH-53
ClassificationSmall molecules
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTokyo University of Pharmacy and Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTokyo University of Pharmacy and Life Sciences
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A